In line with that, platelet activation products were shown to be increased during MPN, such as platelet factor 4, β-thromboglobulin [23], urinary thromboxane metabolites [24], and soluble P-selectin or CD40 [25]. The gene discussed is CD40; the disease is myeloproliferative disorder.